跳至主要内容
临床试验/NCT06255730
NCT06255730招募中不适用

The Effect of Stellate Ganglion Block on Insomnia Patients: a Pre - and Post Control Experiments

Zeng Changhao1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年2月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Pittsburgh Sleep Quality Index

研究概览

简要总结

A prospective study was conducted on Insomnia Patients. All the patients were provided with Stellate Ganglion Block. The quality of sleep was evaluated to see if Stellate Ganglion Block can improve Insomnia.

详细描述

Insomnia is a sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep, despite having adequate opportunity for sleep. It is a common condition that can significantly impact an individual's quality of life and overall well-being.A prospective study was conducted on Insomnia Patients. All the patients were provided with Stellate Ganglion Block. The quality of sleep was evaluated to see if Stellate Ganglion Block can improve Insomnia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Insomnia patients with the ages over
  • Meeting the diagnostic criteria for chronic insomnia as per the International Classification of Sleep Disorders (ICSD) or the Diagnostic and Statistical Manual of Mental Disorders (DSM).
  • Experiencing insomnia symptoms persistently for at least three months.
  • Not currently using or ceased using medication for insomnia for at least four weeks.
  • Willing to undergo Stellate Ganglion Block treatment and participate in the study.

排除标准

  • Patients with severe cardiovascular disease, pulmonary disease, or other serious physical health issues.
  • Pregnant or lactating women.
  • Patients with mental disorders (such as major depression, anxiety disorders, schizophrenia, etc.) or cognitive impairments.
  • Patients with known allergies or contraindications to Stellate Ganglion Block treatment.
  • Patients currently participating in other clinical trials or receiving experimental treatments.

研究组 & 干预措施

Stellate Ganglion Block Group

Experimental

Stellate Ganglion Block Group will be given Stellate Ganglion Block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g), once a day

干预措施: Stellate Ganglion Block (Procedure)

Stellate Ganglion Block Group

Experimental

Stellate Ganglion Block Group will be given Stellate Ganglion Block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g), once a day

干预措施: Lidocaine Hydrochloride (Drug)

结局指标

主要结局

Pittsburgh Sleep Quality Index

时间窗: day 1 and day 10

Pittsburgh Sleep Quality Index (PSQI): The PSQI is a widely used scale that assesses sleep quality, including aspects such as sleep latency, sleep duration, sleep efficiency, sleep disturbances, and daytime dysfunction. The total score ranges from 0 to 21, with higher scores indicating worse sleep quality.

次要结局

  • Sleep Impairment Index(day 1 and day 10)
  • Anxiety(day 1 and day 10)

研究者

发起方
Zeng Changhao
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zeng Changhao

Research Director

People's Hospital of Zhengzhou University

研究点 (1)

Loading locations...

相似试验